Viewing Study NCT03394027

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-03-03 @ 8:19 PM
Study NCT ID: NCT03394027
Status: COMPLETED
Last Update Posted: 2022-08-23
First Post: 2018-01-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
None Endometrial Cancer View
None Hormone Receptor Positive, HER2 Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Imipridones View
None TNBC View
None Metastatic View
None Male Breast Cancer View